We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Rapid UTI Test System Combines an Immunoassay with a Smartphone Camera

By LabMedica International staff writers
Posted on 22 Jan 2020
A team of British bioengineers has combined a rapid microfluidic fluorescence sandwich immunoassay with a smartphone camera to form an assay system for the diagnosis of urinary tract infections (UTIs).

In its initial configuration, the assay is set to detect the bacterium Escherichia coli, which is found in about 80% of bacterial UTIs. More...


The test, as designed by investigators at the University of Bath (United Kingdom), is performed by passing a urine sample over a ridged plastic micro-capillary strip, to which are bound immobilized antibodies able to recognize E. coli bacteria. If E. coli are present in the sample, the antibodies will bind to them, preventing the bacteria from passing through that section of the plastic strip. An enzyme is added that causes a change in color that can be recorded by the smartphone camera. An application determines the concentration of E. coli in the sample by analyzing the image taken by the camera.

A prototype of the system operating with E. coli in synthetic urine was shown to be able to detect a minimal concentration of 240 CFU/mL (colony forming units per milliliter) of bacteria, compatible with cut-off levels for UTIs. The test took less than 25 minutes and did not require any sample preparation or concentration.

Senior author Dr. Nuno Reis, reader in the department of chemical engineering at the University of Bath, said, "The test is small and portable - so it has major potential for use in primary care settings and in developing countries. Currently, bacterial infections in UTIs are confirmed via microbiological testing of a urine sample. That is accurate, but time-consuming, taking several days. We hope that giving medical professionals the ability to quickly rule in or rule out certain conditions will allow them to treat patients more quickly and help them make better decisions about the prescription of antibiotics. The smartphone solves one of the biggest problems of the decentralizing of diagnostics because their capabilities are actually very sophisticated in certain conditions. They offer the same functionality as sophisticated scanners that have until now been available only in labs."

The rapid UTI test was described in the December 1, 2019, online edition of the journal Biosensors and Bioelectronics.

Related Links:
University of Bath


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Microbiology

view channel
Image: Graphical Abstract (Emery, J. K., V. Nemidkanam, N. Colon, et al. Journal of Extracellular Vesicles (2026). https://doi.org/10.1002/jev2.70286)

Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori

Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.